Patents for C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203) |
---|
02/27/2003 | WO2003016254A1 Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient |
02/27/2003 | WO2003015517A1 Agonists and antagonists of 5h3-like receptors of invertebrate s as pesticides |
02/27/2003 | US20030040520 For therapy of cancer |
02/27/2003 | CA2457468A1 Carboxylic acid derivatives and pharmaceutical agent comprising the same as active ingredient |
02/27/2003 | CA2456932A1 N-heterocyclyl substituted thienyloxy-pyrimidines used as herbicides |
02/27/2003 | CA2456290A1 Agonists and antagonists of 5h3-like receptors of invertebrate s as pesticides |
02/26/2003 | EP1100797B1 Heterocyclic compounds as inhibitors of rotamase enzymes |
02/26/2003 | CN1399622A Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
02/25/2003 | US6525082 Apoptosis inducer |
02/25/2003 | US6525051 For treating cytokine-induced hypotension, inflammatory bowel disease, cerebral ischemia, arthritis, adult respiratory distress syndrome, asthma |
02/21/2003 | WO2002024660A1 Imidazole derivatives or their salts |
02/21/2003 | CA2420945A1 Imidazole derivatives or their salts |
02/20/2003 | WO2003014075A2 Novel gamma secretase inhibitors |
02/20/2003 | WO2003014071A1 Benzoylcyclohexenone derivatives |
02/20/2003 | WO2003013518A1 Alpha-ketoamide derivatives as cathepsin k inhibitors |
02/20/2003 | WO2002049993A3 High affinity small molecule c5a receptor modulators |
02/20/2003 | US20030036543 Especially as inhibitors of Aurora-2 and GSK-3, for treating diseases such as cancer, diabetes and Alzheimer's disease. |
02/20/2003 | CA2456241A1 Benzoylcyclohexenone derivatives |
02/19/2003 | EP1284267A1 Triazole compounds having amide linkage |
02/19/2003 | EP1283834A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
02/19/2003 | EP1283833A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
02/19/2003 | EP1283832A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
02/19/2003 | EP1283831A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
02/19/2003 | EP1020179A4 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition |
02/19/2003 | EP0920425B1 Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases |
02/19/2003 | CN1398259A Method for producing 2-(1,2,4-triazol-1-YL)-ethanols |
02/18/2003 | US6521759 Aminothiazole inhibitors of cyclin dependent kinases |
02/18/2003 | US6521649 Agricultural and horticultural disease controller and a method for controlling the diseases |
02/13/2003 | WO2003011872A1 Platelet adp receptor inhibitors |
02/13/2003 | WO2003011858A1 Substituted isoindoles and e use thereof |
02/13/2003 | WO2002055492A3 An improved process for preparing pure ondansetron hydrochloride dihydrate |
02/13/2003 | US20030033089 Substituted quinazolines and analogs and the use thereof |
02/13/2003 | CA2468925A1 Platelet adp receptor inhibitors |
02/13/2003 | CA2455772A1 Substituted isoindoles and their use |
02/12/2003 | EP1283199A1 Melanin-concentrating hormone antagonist |
02/12/2003 | EP1283039A1 -secretase inhibitors |
02/12/2003 | CN1101392C Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quindinone derivatives |
02/12/2003 | CN1101391C Farnesyl transferase inhibiting 2-quinolone derivatives |
02/11/2003 | US6518282 4-Arylpiperidine derivatives for the treatment of pruritus |
02/11/2003 | US6517836 Aziridin-1-yl nitrobenzamides as prodrugs in conjunction with nitroreductase enzymes |
02/11/2003 | CA2250391C Butadiene derivatives and process for their preparation |
02/06/2003 | WO2003010158A1 Novel compounds |
02/06/2003 | WO2002067851A3 Method for treating fibrotic diseases or other indications iiic |
02/06/2003 | WO2002059112A3 Pyrazole compounds useful as protein kinase inhibitors |
02/06/2003 | US20030028022 Preferably tertiary amines comprising tetrahydroquinoline and benzimidazole; use treating human immunodeficiency virus (HIV) and Feline Immunodeficiency Virus (FIV) |
02/06/2003 | US20030027831 Arylpiperzine derivatives are useful for treatment of anxiety, depression, hypertension, cognitive disorders, sexual dysfunction, brain trauma, memory loss, eating disorders, obesity, substance abuse, and obsessive-compulsive diseases |
02/06/2003 | US20030027815 10-(4-cyclohexylbenzoyl)-10,11-dihydro-5H-pyrrolo(2,1-c)(1,4)b enzodiazepine derivatives, useful for suppression of disorders which may be remedied or alleviated by oxytocin antagonist activity, including premature labor |
02/06/2003 | US20030027794 N-heterocyclic derivatives as NOS inhibitors |
02/05/2003 | EP1280795A2 N-substituted carbamoyloxyalkyl-azolium derivatives |
02/05/2003 | EP0742201B1 Process for producing aromatic or heteroaromatic sulfur compounds |
02/05/2003 | EP0730616B1 Process for preparing polyazamacrocycles |
02/05/2003 | CN1395568A 1,2-diaryl benzimidazole derivative for treating illnesses associated with microglia activation |
02/05/2003 | CN1395566A Corticotropin releasing factor antagonists |
02/05/2003 | CN1395558A Substituted benzoylguanidines, method for their production, their use as medicament or diagnostic agent and mediciment containing same |
02/05/2003 | CN1100777C N-heterocyclic derivatives as NOS inhibitor |
02/05/2003 | CN1100759C Xanthene and arcridine derivative and its use |
02/04/2003 | US6515024 Succinoylamino hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors |
02/04/2003 | US6515005 Substituted azole derivatives as inhibitors of corticotropin releasing factor |
02/04/2003 | US6515004 Useful in the treatment of Alzheimer's disease, chemotherapy-induced alopecia, and cardiovascular disease |
02/04/2003 | US6514990 Pharmaceutically active compounds and methods of use |
02/04/2003 | US6514983 Inhibitors of the nucleic enzyme poly(adenosine 5'-diphospho-ribose)polymerase |
02/04/2003 | US6514976 Arylpiperazines having activity at the serotonin 1A receptor |
01/30/2003 | WO2003008398A1 Aryl substituted thiazolidinones and the use thereof |
01/30/2003 | WO2003008391A1 Azole compounds as anti-fungal agents |
01/30/2003 | WO2003007958A1 Tetrahydroquinoxalines acting as bradykinin antagonists |
01/30/2003 | WO2003007946A1 Secondary 1,3-thiazole-5-yl sulfonamide derivatives and their use as antiviral agents |
01/30/2003 | WO2003007942A1 Substituted isoindoles and the use thereof |
01/30/2003 | US20030022885 Pyrazole compounds useful as protein kinase inhibitors |
01/30/2003 | US20030022794 Bioactive pesticides |
01/30/2003 | US20030019050 Novel cationic 4-hydroxyindoles, their use for the oxidation dyeing of keratinous fibers, dyeing compositions, and methods of dyeing |
01/30/2003 | CA2454007A1 Tetrahydroquinoxalines acting as bradykinin antagonists |
01/30/2003 | CA2453650A1 Substituted isoindoles and the use thereof |
01/30/2003 | CA2453633A1 Aryl substituted thiazolidinones and the use thereof |
01/29/2003 | EP1279666A1 1-diphenylmethyl-pyrazole derivatives as opioid receptor ligands |
01/29/2003 | EP1279662A1 Process for preparing phenylcyclohexan-1-ylcarboxylic acids |
01/29/2003 | EP1278755A2 Azole compounds as therapeutic agents for fungal infections |
01/29/2003 | EP1278735A1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents |
01/29/2003 | EP1278723A2 P-(sulfonyl)-aryl and -heteroaryl amines |
01/29/2003 | EP1192145A4 Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines |
01/29/2003 | EP0846113B1 1-(pyridyl)-pyrazols and their use as herbicides |
01/29/2003 | CN1394205A Indazole compounds, pharmaceutical compositions, and their use for mediating or inhibiting cell proliferation |
01/29/2003 | CN1100031C Cyclohexane derivatives |
01/28/2003 | US6512116 No drug resistance; intravenous |
01/28/2003 | US6512001 D-proline derivatives |
01/28/2003 | US6511990 Class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof |
01/28/2003 | US6511974 Non-peptidic and have good oral bioavailability, specific vasopressin V2 agonists, therefore do not raise blood pressure |
01/28/2003 | US6511681 Solubility and bioavailability of azole antifungal medicaments |
01/24/2003 | WO2002016308A1 Phenyl- and phenylalkyl-substituted ethanolamines and ethylenediamines |
01/24/2003 | CA2394209A1 1-diphenylmethyl-pyrazole derivatives as opioid receptor ligands |
01/23/2003 | WO2003006456A1 4-substituted-picolinic acid amide derivates useful as fungicides |
01/23/2003 | WO2003006440A2 Amide-containing compound having improved solubility and method of improving the solubility of an amide-containing compound |
01/23/2003 | WO2003006436A1 Novel azole or triazole derivatives, method for preparing same and use thereof as fungicides |
01/23/2003 | WO2002050066A3 Pyrazole compounds useful as protein kinase inhibitors |
01/23/2003 | US20030018201 Method for producing 2-(1,2,4-Triazol-1-yl)-ethanols |
01/23/2003 | US20030018190 Valency platform molecules comprising carbamate linkages |
01/23/2003 | US20030018029 Tyrosine kinase inhbitor; antiproliferative agents |
01/23/2003 | CA2452513A1 Amide-containing compound having improved solubility and method of improving the solubility of an amide-containing compound |
01/22/2003 | EP1277729A1 Ppar (gamma) modulators |
01/22/2003 | EP1276743A1 Ion liquids derived from lewis acid based on titanium, niobium, tantalum, tin or antimony, and uses thereof |
01/22/2003 | EP1276732A1 Amides of r-2-(aminoaryl)-propionic acids for use in theprevention of leucocyte activation" |